Would the FDA not have asked for all trial results up until end of trial from monotherapy if COVID-19 did not exist? Other clinical trials also had trouble with enrollment because of COVID. I thought leronlimab approval for COVID would clear up the fear and restart our other trials. But we'll continue to be delayed on those.